Jennifer Nessel, Assistant Editor

The literature review indicated that there was a significant need for human trafficking (HT) training within emergency departments (ED) and pharmacy school curriculum.

The Neostigmine Methylsulfate Injection is the first manufacturer-prepared, ready-to-administer prefilled syringe on the market.

Expanded mental health care at HIV clinics across the United States could help in reaching the goal of viral suppression among 90% of the population.

The Impassion130 trial evaluated whether atezolizumab plus nanoparticle albumin-bound paclitaxel increased overall survival in patients with triple negative breast cancer when compared to chemotherapy alone.

Findings presented at the 2019 ASCO meeting show venetoclax plus obinutuzumab induced deep, high, and long-lasting minimal residual disease negativity in chronic lymphocytic leukemia.

The multi-national phase 3 clinical trial on the novel drug as a treatment option for patients with advanced bladder cancer after they’ve received standard chemotherapy and immune treatments.

Updated analysis shows favorable survival outcomes with nivolumab and ipilimumab and provides evidence of long-term survival in patients with advanced melanoma.

Study could lead to advances in HIV vaccine development because functional immunity to HIV is needed from a vaccine.

Researchers studied the quality of life, pain, Global Health Status, and adverse effects.

A study investigates whether a high-dose of vitamin D with or without exercise is a safe, effective option to prevent bone loss.

To elevate the burden on many patients with HER2-positive breast cancer, investigators tested whether a targeted therapy of trastuzumab emtansine plus pertuzumab would lead to a safer option than traditional therapy.

Daily servings of fruits, vegetables, and grains associated with a lower risk of death from breast cancer.

With a cohort of approximately 50,000, this may be the largest exome sequencing study of type 2 diabetes.

Although recent trials for Merck's pembrolizumab injection demonstrated promise for recurrent or metastatic head and neck squamous cell carcinoma, testing for patients with metastatic triple-negative breast cancer did not meet the primary endpoint.

The survey looked into the participants’ confidence of specific approaches, including outcome-related measures, fee-for-service, intermediate outcome, and outcome-related measures.

Nearly half of evaluable patients with rare central nervous system tumors, neuroblastoma, or other solid tumors had responses to entrectinib.

Lowest test dose of oxaliplatin and capecitabine was comparable to the highest dose in delaying advanced gastroesophageal cancer progression and minimizing adverse effects.

Lenalidomide found to prevent the formation of blood vessels that feed tumors, yet carries significant adverse effects.

National Cancer Institute-Children’s Oncology Group Pediatric Molecular Analysis for Therapy Choice is the first nationwide precision oncology trail for patients with cancers that have not responded to standard treatments.

The study included an analysis detailing crash and traffic violation records for newly licensed drivers. It is the first large-scale longitudinal study on this topic.

Researchers seek to investigate how to broaden the potential of cediranib with and olaparib to treat multiple cancer types.

Understanding what constitutes a 'good' immune response to HIV may provide important information for vaccine design and intervention.

Among the most prevalent symptoms of chimeric antigen receptor T-cell therapy is encephalopathy.

Study suggests a possible co-treatment strategy to overcome resistance to Venetoclax in the treatment of chronic lymphocyte leukemia and acute myeloid leukemia.

Study examines cutting off glutamine and fatty acids, two well-known cancer food sources that tumors use to grow and survive.

Research may lead to potential new targets for preventing cancer in humans.

Study suggests future interventions targeting improvements in cancer screenings may need to focus on the time of day when a patient visits a doctor.

The study focused on the comparative risk of infection across 7 systemic biologics.

Civica has made plans to deliver 14 essential generic medications this year.

This report revealed that in 2016, an estimated 3900 of 4200 or 93% incident HIV infections among black women would not have occurred if the incidence for black women were the same as that for white women.